Related Experiment Video
Updated: May 26, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
MiR-224-3p regulates ferroptosis and inflammation in lens epithelial cells by targeting ACSL4
1Department of Ophthalmology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, 233004, China.
Abstract:
In this study, we investigated the expression levels of miR-224-3p and inflammatory factors in the lens epithelium of patients with high myopia cataract (HMC) to determine how miR-224-3p/ACSL4 affects ferroptosis and inflammation in human lens epithelial cells (HLECs). The capsule tissues (including lens epithelial cells) of 36 patients with HMC and 36 patients with age-related cataract (ARC) were taken respectively. 18HMC and 18ARC capsule tissues were selected for RNA sequencing (RNA-Seq) and the rest were used for qPCR assays. The expression of miR-224-3p and ACSL4 in the capsules of patients was detected by qPCR, and RNA was extracted from each of the six capsules. To evaluate ferroptosis and inflammation, the levels of expression of ACSL4, GPX4, TFR1 and IL-6 was determined by immunohistochemistry, Transmission electron microscopy image showed the structure of mitochondria. The differential expression of mir-224-3p was identified through RNA sequencing, with its expression significantly increased in HMC. As a result, mir-224-3p was chosen for further experimentation. The expression levels of ACSL4, TFR1 and GPX4 varied between HMC and ARC. Target Scan predicted a direct binding site between mir-224-3p and ACSL4. The results showed that the expression levels of miR-224-3p, TFR1 and IL-6 in the HMC patients were significantly greater than those in ARC. ACSL4 and GPX4 in HMC were considerably lower than those in ARC. Electron microscopy images revealed that the mitochondria of HMC were significantly shrunken compared to those of ARC. So it was thought that ferroptosis and inflammation occured in HMC patients. A dual-luciferase report found miR-224-3p regulated ACSL4. PCR and WB assays revealed that ACSL4 was the downstream target gene of miR-224-3p. We also found that miR-224-3p promoted the proliferation and migration of HLECs. TNF-α (20 ng/mL) induced an inflammatory response in HLECs. Also, miR-224-3p effectively inhibited ferroptosis in HLECs induced by erastin, meanwhile the expression levels of Fe2+, MDA, ROS, and TFR1 were reduced, while GPX4 and GSH expression levels were elevated. The level of expression of IL-6 was decreased. Additionally, miR-224-3p increased the viability of HLECs by regulating ferroptosis and inflammation via ACSL4 targeting.
Insights
MicroRNA-224-3p (miR-224-3p) protects against ferroptosis and inflammation in high myopia cataract (HMC) by targeting ACSL4. This finding offers potential therapeutic strategies for HMC by modulating miR-224-3p levels.
Area of Science:
- Ophthalmology
- Molecular Biology
- Cell Biology
Background:
- High myopia cataract (HMC) is associated with lens epithelial cell dysfunction.
- Ferroptosis and inflammation are implicated in cataract development.
- The role of microRNAs in HMC pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the expression of miR-224-3p and its target ACSL4 in HMC.
- To determine the effect of miR-224-3p on ferroptosis and inflammation in human lens epithelial cells (HLECs).
- To explore the therapeutic potential of miR-224-3p in HMC.
Main Methods:
- RNA sequencing and qPCR to analyze gene expression in HMC and age-related cataract (ARC) tissues.
- Immunohistochemistry and transmission electron microscopy to assess cellular and mitochondrial changes.
- Dual-luciferase reporter assays and Western blot to confirm the interaction between miR-224-3p and ACSL4.
- In vitro experiments using HLECs treated with TNF-α and erastin to induce inflammation and ferroptosis.
Main Results:
- miR-224-3p expression was significantly upregulated in HMC compared to ARC.
- ACSL4 expression was downregulated in HMC, and it was identified as a direct target of miR-224-3p.
- miR-224-3p inhibited erastin-induced ferroptosis by reducing Fe2+, MDA, and ROS levels, and increasing GPX4 and GSH levels.
- miR-224-3p suppressed TNF-α-induced inflammation by decreasing IL-6 expression.
- miR-224-3p promoted HLEC proliferation and migration, and increased cell viability by regulating ferroptosis and inflammation via ACSL4.
Conclusions:
- miR-224-3p plays a protective role in HMC by suppressing ferroptosis and inflammation.
- The miR-224-3p/ACSL4 axis is a key regulator of these processes in HLECs.
- Targeting miR-224-3p may represent a novel therapeutic strategy for HMC.

